B Karajgi

638 total citations
10 papers, 453 citations indexed

About

B Karajgi is a scholar working on Psychiatry and Mental health, Pharmacology and Surgery. According to data from OpenAlex, B Karajgi has authored 10 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in B Karajgi's work include Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (3 papers) and Epilepsy research and treatment (2 papers). B Karajgi is often cited by papers focused on Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (3 papers) and Epilepsy research and treatment (2 papers). B Karajgi collaborates with scholars based in United States, United Kingdom and Jamaica. B Karajgi's co-authors include Arthur Rifkin, Seshagiri Doddi, Michael Borenstein, Simcha Pollack, Robert Dicker, David M. Shaw, Thomas B. Cooper, S. F. Tidmarsh, DavidM. Shaw and T B Cooper and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

B Karajgi

10 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Karajgi United States	10	238	149	87	77	61	10	453
B. H. Burns United Kingdom	10	373 1.6×	96 0.6×	51 0.6×	97 1.3×	32 0.5×	15	628
Seshagiri Doddi United States	9	189 0.8×	131 0.9×	89 1.0×	77 1.0×	62 1.0×	12	404
Michael T. Isaac United Kingdom	7	100 0.4×	72 0.5×	48 0.6×	79 1.0×	40 0.7×	18	388
Joseph K. Stanilla United States	11	388 1.6×	106 0.7×	35 0.4×	81 1.1×	17 0.3×	23	703
Louis Vachon United States	11	125 0.5×	60 0.4×	29 0.3×	45 0.6×	65 1.1×	15	449
Jan Jaracz Poland	13	232 1.0×	94 0.6×	136 1.6×	22 0.3×	41 0.7×	34	550
P. Mesters Belgium	11	252 1.1×	88 0.6×	136 1.6×	56 0.7×	30 0.5×	19	578
G M Simpson United States	11	329 1.4×	160 1.1×	36 0.4×	29 0.4×	15 0.2×	17	647
Amanda Degenhardt Canada	6	411 1.7×	129 0.9×	35 0.4×	44 0.6×	25 0.4×	6	687
Mary E. Swigar United States	14	216 0.9×	114 0.8×	29 0.3×	11 0.1×	34 0.6×	30	470

Countries citing papers authored by B Karajgi

Since Specialization

Citations

This map shows the geographic impact of B Karajgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Karajgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Karajgi more than expected).

Fields of papers citing papers by B Karajgi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Karajgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Karajgi. The network helps show where B Karajgi may publish in the future.

Co-authorship network of co-authors of B Karajgi

This figure shows the co-authorship network connecting the top 25 collaborators of B Karajgi. A scholar is included among the top collaborators of B Karajgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Karajgi. B Karajgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Karajgi, B, et al.. (2009). Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia. Journal of Clinical Psychopharmacology. 29(3). 255–258. 39 indexed citations

2.

Rifkin, Arthur, et al.. (1997). Lithium treatment of conduct disorders in adolescents. American Journal of Psychiatry. 154(4). 554–555. 71 indexed citations

3.

Rifkin, Arthur, et al.. (1994). Dosage of Haloperidol for Mania. The British Journal of Psychiatry. 165(1). 113–116. 31 indexed citations

4.

Doddi, Seshagiri, Arthur Rifkin, B Karajgi, Thomas B. Cooper, & Michael Borenstein. (1994). Blood Levels of Haloperidol and Clinical Outcome in Schizophrenia. Journal of Clinical Psychopharmacology. 14(3). 187???195–187???195. 13 indexed citations

5.

Rifkin, Arthur, et al.. (1991). Dosage of Haloperidol for Schizophrenia. Archives of General Psychiatry. 48(2). 166–166. 78 indexed citations

6.

Karajgi, B, et al.. (1990). The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. American Journal of Psychiatry. 147(2). 200–201. 172 indexed citations

7.

Rifkin, Arthur, B Karajgi, Seshagiri Doddi, & T B Cooper. (1990). Dose and blood levels of haloperidol in treatment of mania.. PubMed. 26(1). 144–6. 9 indexed citations

8.

Rifkin, Arthur, et al.. (1989). Benzodiazepine use and abuse by patients at outpatient clinics. American Journal of Psychiatry. 146(10). 1331–1332. 20 indexed citations

9.

Shaw, DavidM., et al.. (1982). Time course of plasma drug levels during once-daily oral administration of clomipramine. Psychopharmacology. 77(4). 344–347. 10 indexed citations

10.

Shaw, David M., S. F. Tidmarsh, & B Karajgi. (1980). Tryptophan, affective disorder and stress. Journal of Affective Disorders. 2(4). 321–325. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact